Collaborate to accelerate drug discovery for rare and neglected diseases

What we do

We develop potential therapeutics through our extensive researcher and foundation networks.

We identify research that can be readily translated to treatments for rare and neglected diseases.

We provide the drug discovery preclinical and clinical expertise to move therapeutics towards the clinic.

To find out more about our capabilities please contact us

See our poster from the 2019 GRS in Tropical Infectious Diseases.

See some of our collaborations

High-throughput screening and Bayesian machine learning for copper-dependent inhibitors of Staphylococcus aureus

Halogen Substitution Influences Ketamine Metabolism by Cytochrome P450 2B6: In Vitro and Computational Approaches

Comparing Multiple Machine Learning Algorithms and Metrics for Estrogen Receptor Binding Prediction

Assessment of Substrate Dependent ligand Interactions at the Organic Cation Transporter OCT2 Using Six Model Substrates